| http://www.w3.org/ns/prov#value | - Project investigators suspect that a patient???s defense mechanisms may determine the rate of IPF progression based on evidence such as observations that progression of IPF varies widely among patients, and that treatment with an immune-boosting cytokine can have a positive effect on survival, even though it does not improve lung function.
|
